#pharmaceuticals
Pharma executive collapses during Trump’s Oval Office event on obesity drug prices
A senior pharmaceutical executive collapsed during an Oval Office event where former U.S. President Donald Trump was announcing a new initiative to reduce the prices of obesity drugs. The incident caused a sudden interruption to the live broadcast of the announcement, which was centered on a major agreement between the Trump administration and leading pharmaceutical manufacturers. According to eyewitnesses, the executive, later identified as Gordon Findlay of Novo Nordisk, lost his
Pharma executive collapses during Trump’s Oval Office event on obesity drug prices
A senior pharmaceutical executive collapsed during an Oval Office event where former U.S. President Donald Trump was announcing a new initiative to reduce the prices of obesity drugs. The incident caused a sudden interruption to the live broadcast of the announcement, which was centered on a major agreement between the Trump administration and leading pharmaceutical manufacturers. According to eyewitnesses, the executive, later identified as Gordon Findlay of Novo Nordisk, lost his
Torrent Pharmaceuticals to Hold Meeting for Interim Dividend on Jan. 24
Torrent Pharmaceuticals Ltd. will hold a meeting on January 24 to consider the payment of an interim dividend for the financial year 2024-25. The company has set February 1 as the record date for determining the eligible members for the dividend payment, if declared. The interim dividend will be for the equity shares of Rs 5 each. Earlier, Samir Mehta, President of the Indian Pharmaceutical Alliance and Chairperson of Torrent Group, highlighted the industry's plans to grow signi
Torrent Pharmaceuticals to Hold Meeting for Interim Dividend on Jan. 24
Torrent Pharmaceuticals Ltd. will hold a meeting on January 24 to consider the payment of an interim dividend for the financial year 2024-25. The company has set February 1 as the record date for determining the eligible members for the dividend payment, if declared. The interim dividend will be for the equity shares of Rs 5 each. Earlier, Samir Mehta, President of the Indian Pharmaceutical Alliance and Chairperson of Torrent Group, highlighted the industry's plans to grow signi
India's Pharma Industry Set for Major Growth and Innovation in 2025
In 2025, the Indian pharmaceutical industry is set for a profound transformation driven by innovation, research excellence, and expanded global access. With the industry projected to reach USD 130 billion by 2030, India aims to become a global hub for high-quality, affordable pharmaceuticals, focusing on areas like CAR-T cell therapy, mRNA vaccines, and biosimilars. Technological advancements like AI, machine learning, and precision medicine are expected to revolutionize drug discovery, manuf
India's Pharma Industry Set for Major Growth and Innovation in 2025
In 2025, the Indian pharmaceutical industry is set for a profound transformation driven by innovation, research excellence, and expanded global access. With the industry projected to reach USD 130 billion by 2030, India aims to become a global hub for high-quality, affordable pharmaceuticals, focusing on areas like CAR-T cell therapy, mRNA vaccines, and biosimilars. Technological advancements like AI, machine learning, and precision medicine are expected to revolutionize drug discovery, manuf









